Location History:
- Overland Park, KS (US) (2016 - 2020)
- Clifton, NJ (US) (2017 - 2020)
Company Filing History:
3 out of 4 
3 out of 320 
1 out of 1 Years Active: 2016-2020
Title: The Innovative Contributions of Keith Jensen
Introduction
Keith Jensen, an accomplished inventor based in Clifton, NJ, has made significant strides in the field of pharmaceuticals. With a total of three patents to his name, Jensen is recognized for his innovative solutions aimed at improving drug delivery systems, particularly through transmucosal routes.
Latest Patents
Among his latest contributions is the patent for a transmucosal administration system for pharmaceutical drugs. This invention focuses on administering quinones and benzoquinones, specifically 1,4-benzoquinones, via the oromucosal route. This method enhances the efficiency of drug delivery, ensuring that medications can be absorbed more effectively by the body.
Career Highlights
Keith Jensen has had a notable career, having worked with reputable companies such as LTS Lohmann Therapie-Systeme AG and Santhera Pharmaceuticals (Schweitz) AG. His roles in these organizations have allowed him to apply his innovative ideas in real-world applications, driving advancements in pharmaceutical technologies.
Collaborations
Throughout his career, Jensen has collaborated with talented professionals, including Markus Krumme and Judith Dubach-Powell. These partnerships have enabled him to broaden his perspective and enhance the creative process in developing new therapeutic solutions.
Conclusion
In conclusion, Keith Jensen stands out as a remarkable inventor in the pharmaceutical industry. His patents reflect his commitment to advancing drug delivery methods, showcasing the importance of innovation in medicine. As the landscape of pharmaceuticals continues to evolve, inventors like Jensen play a critical role in shaping a healthier future.